Clinical trial
Sporozoite Challenge of Polyprotein Vaccinees
NCT00375128 · European Vaccine Initiative, Other · Completed
Key facts
| NCT number | NCT00375128 |
|---|---|
| Title | Sporozoite Challenge of Polyprotein Vaccinees |
| Official title | Assessment of Protection Against Malaria by Sporozoite Challenge of Healthy Adults Vaccinated With the Polyprotein Malaria Vaccines 'FP9-PP, MVA-PP' and Control Non-Vaccinated Volunteers |
| Lead sponsor | European Vaccine Initiative, Other |
| Collaborators | University of Oxford Wellcome Trust Walter Reed Army Institute of Research (WRAIR) U.S. Fed |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Biological |
| Interventions | FP9-PP (FP9 polyprotein), MVA-PP (Modified Virus Ankara polyprotein) |
| Enrollment | 26 |
| Start date | Sep 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Sep 12, 2006 |
| Last update posted | Oct 19, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: